TLSI

TriSalus Life Sciences, Inc.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001826667 Healthcare & Medical Devices

$3.62 +0.03 (+0.84%)

Oct 26 4:00 PM ET · prev $3.59

Market cap

$225.4M

Micro cap

Consensus

Buy

91% Buy or better · 11 analysts

Median target

$11.00

+204% · range $7.00–14.00

Next earnings

Nov 10

in 14 days · EPS est. −$0.13

1 year

−27.9%

from $5.02 · Oct 27

30 days

−17.5%

from $4.39

52-week range

$2.52–7.50

−52% from high · low May 14

Avg volume 20D

176.7K

Sep 30 spike 627.0K

Short interest

🔒 Subscribers only

Insider net

+$3.2M

5 buyers · 5 sellers · since Feb 23

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BULLISH 4 reports · latest

Balance 0 bearish · 2 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 2/4 ·Next Earnings date, Nov 10, 2026

Strongest BULLISH A cluster of five major passive index funds (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley)…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

B Feb 23 2 insiders buy $1.5M at $4.10
R Mar 5 TriSalus Life Sciences reported strong financial results for Q4 and…
S Mar 11 to Mar 17 4 days of insider sells: $134.4K by 5 insiders, avg $3.99
B May 15 5 insiders buy $1.8M at $2.51
S May 15 1 insider sell $1.4K at $2.67
A Sep 9 HC Wainwright & Co. initiates
S Oct 5 3 insiders sell $4.1K at $4.39

Signal stack

Where each data set points today.

InsidersBULLISH

5 insiders bought $3.3M at an average $3.04. 5 insiders sold $139.9K. Price is 19% above their cost.
InstitutionsBULLISH

Q2 2026: 30 added (0 new), 1 trimmed or exited.
AnalystsBULLISH

10 of 11 rate it Buy or better. Every target is above the price.
EstimatesFALLING

Current-quarter EPS estimate −$0.102 → −$0.128 over 90 days.
TrendDOWNTREND

21% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
BlackRock, Inc.	ADD	2,659,218	$12.1M
VANGUARD CAPITAL MANAGEMENT LLC	ADD	1,729,385	$7.9M
Cerity Partners LLC	DOUBLED	1,603,538	$7.3M
GEODE CAPITAL MANAGEMENT, LLC	ADD	1,190,067	$5.4M
STATE STREET CORP	ADD	610,963	$2.8M
NORTHERN TRUST CORP	ADD	379,572	$1.7M
VANGUARD PORTFOLIO MANAGEMENT LLC	ADD	329,464	$1.5M
VANGUARD FIDUCIARY TRUST CO	ADD	320,956	$1.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts

Buy 91% rate it Buy or better

Strong Buy2Buy8Hold1Sell0Strong Sell0

12-month targets · 5 analysts

$3.62 $7.00 $11.00 $14.00

Price is below the lowest target. Median implies +204%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Sep 23, 2026	HC Wainwright & Co. MAINTAIN	MAINTAIN	Buy
Sep 9, 2026	HC Wainwright & Co. INITIATE	INITIATE	Buy
May 13, 2026	Lake Street MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

$3.3M

bought · 5 insiders

$139.9K

sold · 5 insiders

+18.9%

vs their $3.04 cost

Date	Insider	Type	Value
Oct 5, 2026	Szela Mary T CEO and President	TAX W/H	$11.8K
Oct 5, 2026	Stevens Jennifer Chief Regulatory Officer	SELL	$1.4K
Oct 5, 2026	Marshak Richard Chief Commercial Officer	SELL	$1.4K
Oct 5, 2026	Cox Bryan F. Chief of Research	SELL	$1.3K
Jul 1, 2026	Patience David Chief Financial Officer	TAX W/H	$65.3K
Jun 30, 2026	Szela Mary T CEO and President	AWARD	$15.4K
Jun 30, 2026	Marshak Richard Chief Commercial Officer	AWARD	$2.2K
Jun 29, 2026	Marshall Richard Henry Chief Medical Officer	AWARD	60,000 sh

Earnings setup

Estimates

Nov 10

reports in 14 days

−$0.13

EPS estimate, this quarter

−25%

estimate change, 90 days

Current-quarter EPS estimate

−$0.102

90d

−$0.102

60d

−$0.125

30d

−$0.124

−$0.128

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.13	-$0.15–-$0.09	-2.4%	$14.0M
Next Q	-$0.06	-$0.11–-$0.04	+8.1%	$18.8M
Current FY	-$0.33	-$0.39–-$0.27	+0.0%	$53.1M
Next FY	-$0.26	-$0.38–$0.02	-1.5%	$74.5M